New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
11:10 EDTAEO, S, AGN, ACAS, CZR, MONT, CLNE, ESIOptions with increasing implied volatility
Options with increasing implied volatility: UVXY ESI CZR S SVXY CLNE ACAS AEO MONT AGN
News For ESI;CZR;S;CLNE;ACAS;AEO;MONT;AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
November 17, 2014
09:32 EDTAGNValeant says cannot justify paying $219 per share for Allergan
Valeant Pharmaceuticals (VRX) commented on the announcement that Allergan (AGN) and Actavis (ACT) have entered into a definitive agreement under which Actavis will acquire all outstanding shares of Allergan stock: "We have seen the announcement that Allergan and Actavis have made, and while we will review any such agreement in determining our course of action, Valeant cannot justify to its own shareholders paying a price of $219 or more per share for Allergan. Our business is performing extremely well as evidenced by our third quarter results, our expected strong fourth quarter, and our robust outlook for 2015, and I am confident in our continued ability to generate exceptional shareholder value. We will remain focused on delivering strong organic results and evaluating acquisition opportunities as we always have: prudently, in a disciplined manner, and in the best interests of our shareholders."
09:29 EDTAGNActavis to host conference call
Conference call to discuss the acquisition of Allergan will be held on November 17 at 10:30 am. Webcast Link
09:24 EDTAGNAllergan up over 5% to $209 after agreeing to be acquired by Actavis
Subscribe for More Information
09:21 EDTAGNActavis, Allergan transaction subject to approval of shareholders of both
Subscribe for More Information
09:20 EDTAGNActavis projects at least $1.8B in annual synergies from Allergan transaction
Subscribe for More Information
09:18 EDTAGNActavis sees free cash flow over $8B in 2016 following Allergan acquisition
Subscribe for More Information
09:16 EDTAGNActavis confirms deal to acquire Allergan for $219 in cash, stock
Subscribe for More Information
09:15 EDTAGNActavis confirms deal to acquire Allergan for $219 in cash and shares
Subscribe for More Information
09:10 EDTAGNActavis buying Allergan for $219 per share, CNBC reports
06:05 EDTAGNActavis close to buying Allergan for over $64B, Bloomberg reports
Subscribe for More Information
05:54 EDTCZRStocks with implied volatility movement; BHI CZR
Subscribe for More Information
November 16, 2014
14:02 EDTAGNAllergan, Actavis move closer to deal, WSJ reports
Subscribe for More Information
November 14, 2014
13:40 EDTCZRCaesar's says 'substantial doubt' exists on CEOC continuing as going concern
Subscribe for More Information
12:53 EDTSOmega Advisors gives quarterly update on stakes
NEW STAKES: AerCap Holdings (AER), Nordic American Offshore (NAO), Melco Crown Entertainment (MPEL), Groupon (GRPN), and Ashland (ASH). INCREASED STAKES: QEP Resources (QEP), United Continental (UAL), Cabot Oil & Gas (COG), Actavis (ACT), and KAR Auction Services (KAR). DECREASED STAKES: Sprint (S), SandRidge Energy (SD), Sirius XM Holdings (SIRI), Kinder Morgan (KMI), and Transocean (RIG). LIQUIDATED STAKES: QUALCOMM (QCOM), Ocwen Financial (OCN), Freeport-McMoRan (FCX), Boston Scientific (BSX), and Capital One (COF).
06:23 EDTAEOAmerican Eagle implied volatility of 59 at upper end of index mean range
Subscribe for More Information
November 13, 2014
16:13 EDTMONTMontage Technology sees Q4 revenue $47M-$51M, consensus $46.73M
Subscribe for More Information
16:13 EDTMONTMontage Technology reports Q3 adjusted EPS 40c, consensus 46c
Reports Q3 revenue $46M, consensus $44.6M. Reported Q3 gross margin of 57.9% and operating margin of 20.9%.
15:18 EDTMONTNotable companies reporting before tomorrow's open
Subscribe for More Information
14:05 EDTCZRNew Jersey reports Atlantic City gaming win down 4.4% to $207.23M
Subscribe for More Information
07:23 EDTAGNValeant wooing doctors ahead of hoped for Allergan acquisition, WSJ says
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use